(Q38026790)

English

Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids.

scientific article published on 17 July 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801993%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801993%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

endocannabinoids

0 references

glyceryl 2-arachidonate

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

Antonio Luchicchi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801993%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Marco Pistis

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801993%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

17 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801993%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Molecular Neurobiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801993%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

46

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801993%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801993%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

374-392

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22801993%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

https://scigraph.springernature.com/pub.10.1007/s12035-012-8299-0

0 references

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Molecular characterization of a phospholipase D generating anandamide and its congeners

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

A second endogenous cannabinoid that modulates long-term potentiation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Cannabinoid receptors and their ligands

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

The effect of cannabidiol on mouse hepatic microsomal cytochrome P450-dependent anandamide metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Modulation of anxiety through blockade of anandamide hydrolysis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Endocannabinoids inhibit transmission at granule cell to Purkinje cell synapses by modulating three types of presynaptic calcium channels.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Endocannabinoid-mediated control of synaptic transmission

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Endocannabinoids control the induction of cerebellar LTD.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Cannabinoid signaling in inhibitory autaptic hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

COX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

The endocannabinoid 2-arachidonoylglycerol mediates D1 and D2 receptor cooperative enhancement of rat nucleus accumbens core neuron firing

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Supply and demand for endocannabinoids

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Diacylglycerol lipase is not involved in depolarization-induced suppression of inhibition at unitary inhibitory connections in mouse hippocampus.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Anandamide serves two masters in the brain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

From surface to nuclear receptors: the endocannabinoid family extends its assets

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Biochemistry and pharmacology of endovanilloids

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

TRPV1 channels control synaptic plasticity in the developing superior colliculus.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Polymodal activation of the endocannabinoid system in the extended amygdala

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Endocannabinoid- and mGluR5-dependent short-term synaptic depression in an isolated neuron/bouton preparation from the hippocampal CA1 region.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Protective activation of the endocannabinoid system during ischemia in dopamine neurons.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Endocannabinoid signaling in microglial cells

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia?

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17beta-estradiol

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Anandamide modulates sleep and memory in rats

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Pre-training anandamide infusion within the basolateral amygdala impairs plus-maze discriminative avoidance task in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Pharmacological elevation of anandamide impairs short-term memory by altering the neurophysiology in the hippocampus

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Fatty acid amide hydrolase (FAAH) knockout mice exhibit enhanced acquisition of an aversive, but not of an appetitive, Barnes maze task

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Fatty acid amide hydrolase (-/-) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze task

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

FAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Ghrelin-induced activation of cAMP signal transduction and its negative regulation by endocannabinoids in the hippocampus

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Cannabinoids: a real prospect for pain relief?

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Cannabinoid receptors and pain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptor-mediated endocannabinoid retrograde disinhibition

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

An endocannabinoid mechanism for stress-induced analgesia.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid typ

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Adverse effects of cannabis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Endocannabinoid system and stress and anxiety responses.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Anxiolytic-like properties of the anandamide transport inhibitor AM404.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Cellular accumulation of anandamide: consensus and controversy

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

The endogenous cannabinoid 2-arachidonoylglycerol is intravenously self-administered by squirrel monkeys

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Synaptic plasticity and addiction

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

The selective anandamide transport inhibitor VDM11 attenuates reinstatement of nicotine seeking behaviour, but does not affect nicotine intake

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

The endogenous cannabinoid system modulates nicotine reward and dependence

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Deletion of vanilloid receptor (TRPV1) in mice alters behavioral effects of ethanol

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Involvement of 2-arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Modulation of brain endocannabinoid levels by voluntary alcohol consumption in alcohol-preferring AA rats.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

FAAH and anandamide: is 2-AG really the odd one out?

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Anandamide and vanilloid TRPV1 receptors

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8299-0

21 January 2018

The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of fatty acid amide hydrolase inhibitors on maintenance of cocaine and food self-administration and on reinstatement of cocaine-seeking and food-taking behavior in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postsynaptic endocannabinoid release is critical to long-term depression in the striatum

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of the Endocannabinoid System in Retinal Damage after High Intraocular Pressure–Induced Ischemia in Rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple functions of endocannabinoid signaling in the brain.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonpsychotropic cannabinoid receptors regulate microglial cell migration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levonantradol: A Role for Central Prostanoid Mechanisms?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocannabinoids control spasticity in a multiple sclerosis model

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased severity of stroke in CB1 cannabinoid receptor knock-out mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocannabinoids and neuroprotection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The multiple pathways of endocannabinoid metabolism: a zoom out

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel non-CB1/TRPV1 endocannabinoid-mediated mechanism depresses excitatory synapses on hippocampal CA1 interneurons

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spinal anandamide produces analgesia in neuropathic rats: Possible CB1- and TRPV1-mediated mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents. Non-psychoactive cannabinoids, 'entourage' compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid pyschotropic effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of Ca(2+) influx by cannabinoid and metabotropic glutamate receptors in rat cerebellar cortex requires K(+) channels

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabinoids: a new group of agonists of PPARs

1 reference

https://pubmed.ncbi.nlm.nih.gov/22801993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38026790&oldid=2115254170"